Blockchain Registration Transaction Record

Immunotherapy Before Surgery Boosts Glioblastoma Outcomes

New study shows immunotherapy before surgery improves glioblastoma outcomes, impacting companies like Calidi Biotherapeutics. Learn about the potential shift in cancer treatment protocols.

This news matters because it reveals a potential paradigm shift in treating glioblastoma, a notoriously difficult cancer with poor prognosis. If confirmed in human trials, giving immunotherapy before surgery could become a new standard of care, improving survival rates and quality of life for patients. It also underscores the importance of treatment sequencing in oncology, encouraging more research into neoadjuvant therapies across various cancers.